Skip to content

the Effectiveness of intraoperative leukocyte depletion filter used in autologous blood on bacteremia after liver transplantation.

the Effectiveness of intraoperative leukocyte depletion filter used in autologous blood on bacteremia after liver transplantation: A single-blind (patient) clinical trials

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0004953
Enrollment
220
Registered
2020-04-21
Start date
2020-06-04
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : We perform a superiority test in anticipation that the incidence of bacteremia after liver transplantation will be lower than if the leukocyte depletion filter (transfusion set) is no

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Liver transplant recipients who are 19 years of age or older and need blood transfusion intraoperatively

Exclusion criteria

Exclusion criteria: Pediatric patients under 30 kg and under 19 years old Hepatocellular carcinoma patients Pregnant women and lactating women

Design outcomes

Primary

MeasureTime frame
The difference in the incidence of bacteremia within 7 days after surgery is verified by comparison with a control group.

Secondary

MeasureTime frame
The number of white blood cells 3 days after surgery is verified by comparison with a control group.;The incidence of infectious complications within 30 days after surgery is verified by comparison with a control group.

Countries

Korea, Republic of

Contacts

Public ContactDoyeon Kim

Samsung Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026